Roundtable Video 2. Borderline resectable pancreatic cancer and neoadjuvant therapy
By Alison Shamwana | Started 23rd Nov 2015
IHPBA is delighted to present a series of roundtable discussions on Treatment and Advances in the Surgical Management of Pancreatic Cancer.
The second in the series, this video captures discussion among the panel on topics including defining the borderline resectable pancreatic patient, the importance of imaging quality, venous versus artery involvement considerations, imaging modality choices, and baseline neoadjuvant therapy protocols.
Other chapters:
- Video 1: Preparation and selection of the Pancreatic Surgical Patient
- Video 3: Technical Considerations in Pancreatic Surgery
- Video 4: Locally Advanced pancreatic Cancer
- Video 5: Managing Complications Following Pancreatic Resection
Please note there is a discussion forum at the bottom of this page. If you wish to participate please log in to myHPB.
Participant Background:
Charles Vollmer
Director of Pancreatic Surgery
Co-Chief of Upper Gastrointestinal Oncology at the Abramson Cancer Center
Co-Director of the Penn Pancreatic Cyst Program
Hospital Affiliation: University of Pennsylvania
Expertise: Malignant and benign conditions of the pancreas and biliary system, pancreatitis, pancreatic cystic lesions, pancreatic cancer, and upper gastrointestinal malignancies
Robert C.G. Martin
Sam and Lolita Weakley Professor
Division Director, Division of Surgery
Hospital Affiliation: University of Louisville, Louisville, KY
Expertise: Liver Tumors, Pancreatic, Esophageal, Gastric, Colon, Bile duct, Sarcoma and Melanoma
Professor Michelle de Oliviera
Assistant Professor at University of Zurich
Hospital Affiliation: University of Zurich, Zurich, Switzerland
Professor Nigel Heaton
Professor of Liver Transplant, Hepatobiliary and Pancreatic Surgery
Hospital Affiliation: London Bridge Hospital, London, United Kingdom
Expertise: Living Donor Transplantation, complex hepatobiliary and pancreatic surgery, liver transplantation
This video was produced with grant support from our Corporate Partner, AngioDynamics, Inc. Any opinions, findings, conclusions, or recommendations expressed in this video are those of the individuals appearing in the video and do not necessarily reflect the view of AngioDynamics, Inc.